Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine

(2017) Katrijn Grupping et al.   JOURNAL OF INFECTIOUS DISEASES

Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study

(2016) Kosuke Kawai et al.   CLINICAL INFECTIOUS DISEASES

The herpes zoster subunit vaccine

(2016) Anthony L. Cunningham   EXPERT OPINION ON BIOLOGICAL THERAPY

Adjuvant system AS01: helping to overcome the challenges of modern vaccines

(2016) Arnaud M. Didierlaurent et al.   Expert Review of Vaccines

Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States

(2016) Sachiko Ozawa et al.   HEALTH AFFAIRS

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

(2016) Anthony L. Cunningham et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative preclinical evaluation of AS01 versus other Adjuvant Systems in a candidate herpes zoster glycoprotein E subunit vaccine

(2016) Michel Fochesato et al.   Human Vaccines & Immunotherapeutics

VZV skin-test reaction, but not antibody, is an important predictive factor for postherpetic neuralgia

(2015) Kyoko Imoto et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

(2015) Himal Lal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Varicella zoster virus infection

(2015) Anne A. Gershon et al.   Nature Reviews Disease Primers

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients

(2014) E. A. Stadtmauer et al.   BLOOD

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

(2014) Elchonon M. Berkowitz et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study

(2014) Roman Chlibek et al.   VACCINE

Barriers to the Use of Herpes Zoster Vaccine

(2013) Laura P. Hurley   ANNALS OF INTERNAL MEDICINE

Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age

(2013) R. Chlibek et al.   JOURNAL OF INFECTIOUS DISEASES

A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults

(2012) Isabel Leroux-Roels et al.   JOURNAL OF INFECTIOUS DISEASES

Herpes Zoster Incidence Among Insured Persons in the United States, 1993–2006: Evaluation of Impact of Varicella Vaccination

(2011) Jessica Leung et al.   CLINICAL INFECTIOUS DISEASES

Review: The neurobiology of varicella zoster virus infection

(2011) D. Gilden et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

CD4 T Cell Immunity Is Critical for the Control of Simian Varicella Virus Infection in a Nonhuman Primate Model of VZV Infection

(2011) Kristen Haberthur et al.   PLoS Pathogens